Patents by Inventor Paul W. Dempsey

Paul W. Dempsey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230258640
    Abstract: Provided herein are graphene biosensors and related core particles, compositions methods and systems in which more than one pristine graphene sheet is coated with a coating layer of an organic or inorganic material to provide a core graphene particle, to which detectable components comprising a detectable moiety and a peptide linkage are attached through binding of the peptide linkage.
    Type: Application
    Filed: October 31, 2022
    Publication date: August 17, 2023
    Inventors: Paul W. DEMPSEY, Spencer HANTULA, Cristina-Mihaela Sandu APARICIO, Stefan H. BOSSMANN, Christopher M. SORENSEN, Obdulia COVARRUBIAS-ZAMBRANO, Jose COVARRUBIAS
  • Publication number: 20120301883
    Abstract: The invention relates generally to fluid processing and, in particular aspects, processing fluids for detection, selection, trapping and/or sorting of particulate moieties. Sheath flow devices described allow isolation of target species from fluid samples while avoiding non-specific binding of unwanted species to the surfaces of the separation device. Biological fluid processing, detection, sorting or selection of cells, proteins, and nucleic acids is described. The invention finds particular use in diagnostic settings, analyzing a patient's medical condition, monitoring and/or adjusting a therapeutic regimen and producing cell based products.
    Type: Application
    Filed: August 3, 2012
    Publication date: November 29, 2012
    Applicant: CYNVENIO BIOSYSTEMS, INC.
    Inventors: Paul Pagano, Yanting Zhang, Jiangrong Karen Qian, Hyongsok Tom Soh, Paul W. Dempsey, Andre' De Fusco
  • Patent number: 8263387
    Abstract: The invention relates generally to fluid processing and, in particular aspects, processing fluids for detection, selection, trapping and/or sorting of particulate moieties. Sheath flow devices described allow isolation of target species from fluid samples while avoiding non-specific binding of unwanted species to the surfaces of the separation device. Biological fluid processing, detection, sorting or selection of cells, proteins, and nucleic acids is described. The invention finds particular use in diagnostic settings, analyzing a patient's medical condition, monitoring and/or adjusting a therapeutic regimen and producing cell based products.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: September 11, 2012
    Assignee: Cynvenio Biosystems, Inc.
    Inventors: Paul Pagano, Yanting Zhang, Jiangrong Karen Qian, Hyongsok Tom Soh, Paul W. Dempsey, Andreā€² De Fusco
  • Publication number: 20110165122
    Abstract: Compounds compositions and methods of modulating the immune response are provided. The method uses fusion proteins of a cytokine and an antibody to potentiate the action of the cytokine.
    Type: Application
    Filed: November 10, 2010
    Publication date: July 7, 2011
    Applicant: The Regents of the University of California
    Inventors: Arash Shahangian, Genhong Cheng, Lucy S. Cheng, Kham Moc Trinh, Paul W. Dempsey, Beichu Guo, Sherie L. Morrison
  • Publication number: 20110003303
    Abstract: The invention relates generally to fluid processing and, in particular aspects, processing fluids for detection, selection, trapping and/or sorting of particulate moieties. Sheath flow devices described allow isolation of target species from fluid samples while avoiding non-specific binding of unwanted species to the surfaces of the separation device. Biological fluid processing, detection, sorting or selection of cells, proteins, and nucleic acids is described. The invention finds particular use in diagnostic settings, analyzing a patient's medical condition, monitoring and/or adjusting a therapeutic regimen and producing cell based products.
    Type: Application
    Filed: June 10, 2010
    Publication date: January 6, 2011
    Applicant: CYNVENIO BIOSYSTEMS, INC.
    Inventors: Paul Pagano, Yanting Zhang, Jiangrong Karen Qian, Hyongsok Tom Soh, Paul W. Dempsey, Andre' De Fusco
  • Patent number: 6891027
    Abstract: Coupling of C3d molecules or ligands of CD21 or CD19 to an antigen alters the level of immune response to the immunogen upon its administration to an individual. For C3d, the magnitude of the effect is dependent on the number of C3d molecules included in the conjugate. Conveniently, C3d molecules or CD21/CD19 ligands are coupled to an immunogen in fusion polypeptides which may be produced by expression from coding nucleic acid, for instance by culturing host cells containing the nucleic acid. Other means of associating the molecules include chemical cross-linking and co-expression on the surface of a carrier structure. Administration of compositions comprising, in a preferred embodiment, C3d molecules and an immunogen of interest may be used prophylactically (by virtue of the immunological memory induced) or therapeutically. The administration may be for the purpose of raising antibodies to the immunogen. A T-cell response may also be induced.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: May 10, 2005
    Assignee: Cambridge University Technical Services Limited
    Inventors: Douglas T. Fearon, Paul W. Dempsey
  • Publication number: 20020102656
    Abstract: Coupling of C3d molecules or ligands of CD21 or CD19 to an antigen alters the level of immune response to the immunogen upon its administration to an individual. For C3d, the magnitude of the effect is dependent on the number of C3d molecules included in the conjugate. Conveniently, C3d molecules or CD21/CD19 ligands are coupled to an immunogen in fusion polypeptides which may be produced by expression from coding nucleic acid, for instance by culturing host cells containing the nucleic acid. Other means of associating the molecules include chemical cross-linking and co-expression on the surface of a carrier structure. Administration of compositions comprising, in a preferred embodiment, C3d molecules and an immunogen of interest may be used prophylactically (by virtue of the immunological memory induced) or therapeutically. The administration may be for the purpose of raising antibodies to the immunogen. A T-cell response may also be induced.
    Type: Application
    Filed: May 7, 2001
    Publication date: August 1, 2002
    Applicant: Cambridge University Technical Services Limited
    Inventors: Douglas T. Fearon, Paul W. Dempsey
  • Patent number: 6238670
    Abstract: Described herein are compositions which modulate the immune response. In one aspect, a composition is described which comprises an antigen covalently linked to a ligand for CD21(CR2) or CD19. This antigen is not associated with a complement C3 fragment through an ester bond derived from the internal thioester of the complement C3 fragment.
    Type: Grant
    Filed: October 21, 1997
    Date of Patent: May 29, 2001
    Assignee: Cambridge University Technical Services Limited
    Inventors: Douglas T. Fearon, Paul W. Dempsey